Correlation Between Femasys and Heart Test

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Femasys and Heart Test at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Femasys and Heart Test into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Femasys and Heart Test Laboratories, you can compare the effects of market volatilities on Femasys and Heart Test and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Femasys with a short position of Heart Test. Check out your portfolio center. Please also check ongoing floating volatility patterns of Femasys and Heart Test.

Diversification Opportunities for Femasys and Heart Test

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Femasys and Heart is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Femasys and Heart Test Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heart Test Laboratories and Femasys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Femasys are associated (or correlated) with Heart Test. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heart Test Laboratories has no effect on the direction of Femasys i.e., Femasys and Heart Test go up and down completely randomly.

Pair Corralation between Femasys and Heart Test

Given the investment horizon of 90 days Femasys is expected to generate 7.06 times less return on investment than Heart Test. But when comparing it to its historical volatility, Femasys is 4.25 times less risky than Heart Test. It trades about 0.09 of its potential returns per unit of risk. Heart Test Laboratories is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  3.01  in Heart Test Laboratories on December 29, 2024 and sell it today you would earn a total of  1.02  from holding Heart Test Laboratories or generate 33.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy32.79%
ValuesDaily Returns

Femasys  vs.  Heart Test Laboratories

 Performance 
       Timeline  
Femasys 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Femasys are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Femasys showed solid returns over the last few months and may actually be approaching a breakup point.
Heart Test Laboratories 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Heart Test Laboratories are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Heart Test showed solid returns over the last few months and may actually be approaching a breakup point.

Femasys and Heart Test Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Femasys and Heart Test

The main advantage of trading using opposite Femasys and Heart Test positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Femasys position performs unexpectedly, Heart Test can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heart Test will offset losses from the drop in Heart Test's long position.
The idea behind Femasys and Heart Test Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities